Delisting risk
Pasithea Therapeutics (KTTA)
Clinical-stage developer of an oral MEK inhibitor for NF1-related tumors and advanced cancers.
$0.5876
At close+0.02 (+4.37%)
Something off on this page? Send us feedback.
Next report
Nov 12, 2026
estimated · in 70 days
EPS estimate
−$0.21
Revenue estimate
$200.0K
Fiscal quarter
Q3 FY26
EPSReportedEstimate
May '25Aug '25Nov '25Feb '26Mar '26May '26Aug '26Nov '26
Reported−$1.61−$0.66−$0.41−$0.18−$0.89−$0.12−$0.16Pending
Estimate———−$0.18−$0.18−$0.45−$0.16−$0.21
Surprise———0.0%−394.4%+73.3%0.0%—
RevenueReportedEstimate
May '25Aug '25Nov '25Feb '26Mar '26May '26Aug '26Nov '26
Reported———————Pending
Estimate———$200.0K$100.0K$100.0K$300.0K$200.0K
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.21 | — | — |
| Aug 2026 | −$0.16 | −$0.16 | 0.0% |
| Jun 2026 | −$3.40 | — | — |
| May 2026 | −$0.45 | −$0.12 | +73.3% |
| Mar 2026 | −$0.18 | −$0.89 | −394.4% |
| Feb 2026 | −$0.18 | −$0.18 | 0.0% |
The latest year is open to everyone — the 21 quarters behind it read with an account. Sign in | |||
| Nov 2025 | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Dec 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Sep 2021 | |||
| Jun 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 12, 2026 | −$0.21 | — | — | $200.0K | — | — | — |
| Aug 14, 2026 | −$0.16 | −$0.16 | 0.0% | $300.0K | — | — | +0.5% |
| Jun 3, 2026 | −$3.40 | — | — | $300.0K | — | — | — |
| May 15, 2026 | −$0.45 | −$0.12 | +73.3% | $100.0K | — | — | −1.3% |
| Mar 30, 2026 | −$0.18 | −$0.89 | −394.4% | $100.0K | — | — | +3.8% |
| Feb 25, 2026 | −$0.18 | −$0.18 | 0.0% | $200.0K | — | — | −1.6% |
The latest year is open to everyone — the 21 quarters behind it read with an account. Sign in | |||||||
| Nov 13, 2025 | |||||||
| Aug 14, 2025 | |||||||
| May 15, 2025 | |||||||
| Mar 24, 2025 | |||||||
| Nov 13, 2024 | |||||||
| Aug 13, 2024 | |||||||
| May 14, 2024 | |||||||
| Mar 28, 2024 | |||||||
| Dec 29, 2023 | |||||||
| Aug 11, 2023 | |||||||
| May 12, 2023 | |||||||
| Mar 30, 2023 | |||||||
| Nov 14, 2022 | |||||||
| Aug 15, 2022 | |||||||
| May 16, 2022 | |||||||
| Mar 30, 2022 | |||||||
| Nov 18, 2021 | |||||||
| Sep 16, 2021 | |||||||
| Jun 30, 2021 | |||||||
| Dec 31, 2020 | |||||||
| Sep 30, 2020 | |||||||